The news
HealthMosaic has been accepted into the Techstars AI Health accelerator in Baltimore. The program brings a small class of companies working at the intersection of artificial intelligence and clinical care into an intensive three-month cycle of mentorship, customer development, and access to the health systems, research institutions, and investors concentrated in the Baltimore and Washington corridor.
For a company whose product lives inside hospital walls, that proximity matters more than the capital does.
Why we applied
Clinical AI has a data problem before it has a model problem. The models drawing the most attention in healthcare are trained on continuous, high-resolution physiologic data, and most hospitals can only feed them a vital sign every 15 to 60 minutes because bedside devices were never connected to the record in the first place.
We built HealthMosaic to close that gap: connect the monitors, ventilators, and pumps a hospital already owns, normalize what they produce into one real-time stream, and make that stream available to the record and to whichever AI tools a health system chooses to run on top of it. Techstars AI Health is one of the few programs built specifically around that intersection, with mentors who have shipped inside hospitals rather than around them.
Clinical AI has a data problem before it has a model problem.
Why Baltimore
Baltimore is an unusually dense place to build health technology. Major academic medical centers, federal health agencies down the road, a deep bench of clinical researchers, and a growing community of digital health companies all sit within a short drive of one another.
That means shorter feedback loops. When a nurse manager, a biomedical engineering director, and a chief medical information officer can all walk you through what actually breaks on their units, the product gets better faster than any roadmap exercise would produce.
What it means for the hospitals we work with
Nothing about our commitments changes. Existing deployments continue, and the same team stays on them. What the program adds is speed: more clinical validation partners, faster expansion of our device driver library, and more capacity to support the health systems already piloting with us.
If your organization is weighing an AI initiative and is not yet sure whether your device data can support it, this is a good quarter to have that conversation.
